Low VWF–QL is a distinct clinicopathological entity compared with type 2 VWD. buff.ly/X35uyr5 #hemesky

According to new RCSI research, immune cells that 'remember' past inflammation could increase the risk of blood clots in the long term. The 'shortened fuse' in these cells may contribute to a higher blood clot risk in inflammatory conditions. Read more 🔗 www.rcsi.com/dublin/news-... #RCSIdiscover

New RCSI research has uncovered how T cells may contribute to blood clot risk in inflammatory bowel disease. The findings, published in @NatureComms also suggest a potential treatment approach to manage this risk. Read more 🔗 www.rcsi.com/dublin/news-... #RCSIdiscover @rcsi-research.bsky.social

Really good article in @jthjournal.bsky.social about how to deal with persons who have von Willebrand factor levels of 30-50%. The key is how "significant bleeding phenotype" is defined. tinyurl.com/y55mwkj3 #willebrand #VWD